Relation between colour vision loss and occupational styrene exposure level

Occupational and Environmental Medicine

Volumn 59, Issue 12, 2002, Pages 824-829

  Gong, Y Y ^a   Kishi, R ^a   Katakura, Y ^a   Tsukishima, E ^a   Fujiwara, K ^a   Kasai, S ^a   Satoh, T ^a   Sata, F ^a   Kawai, T ^b  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Osaka Occupational Health Service Center   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; CREATININE; GLASS FIBER; MANDELIC ACID; PHENYLGLYOXYLIC ACID; STYRENE;

ADULT; AGE; ALCOHOL CONSUMPTION; ARTICLE; COLOR VISION DEFECT; COLOR VISION TEST; CONTROLLED STUDY; EDUCATION; HUMAN; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MAXIMUM ALLOWABLE CONCENTRATION; OCCUPATIONAL EXPOSURE; PERSONAL MONITORING; PRIORITY JOURNAL; SMOKING; URINE LEVEL;

ADULT; BIOLOGICAL MARKERS; COLOR VISION DEFECTS; CREATININE; ENVIRONMENTAL MONITORING; GLYOXYLATES; HUMANS; MALE; MANDELIC ACIDS; OCCUPATIONAL DISEASES; OCCUPATIONAL EXPOSURE; STYRENE; TIME FACTORS; VISION TESTS;

EID: 0036917871     PISSN: 13510711     EISSN: None     Source Type: Journal    
DOI: 10.1136/oem.59.12.824     Document Type: Article

References (27)

1. Miller RR, Newhook R, Poole A. Styrene production, use, and human exposure. Crit Rev Toxicol 1994;24(suppl):S1-10.
2. Flodin U, Ekberg K, Andersson L. Neuropsychiatric effects of low exposure to styrene. Br J Ind Med 1989;46:805-8.
3. Matikainen E, Forsman-Gronholm L, Pfaffli P, et al. Neurotoxicity in workers exposed to styrene. IARC Sci Publ 1993;127:153-61.
4. Campagna D, Mergler D, Huel G, et al. Visual dysfunction among styrene-exposed workers. Scand J Work Environ Health 1995;21:382-90.
5. Agrawal AK, Srivastava SP, Seth PK. Effect of styrene on dopamine receptors. Bull Environ Contam Toxicol 1982;29:400-3.
6. Mutti A, Romanelli A, Falzoi M, et al. Styrene metabolism and striatal dopamine depletion in rabbits. Arch Toxicol Suppl 1985;8:447-50.
7. Romanelli A, Falzoi M, Mutti A, et al. Effects of some monocyclic aromatic solvents and their metabolites on brain dopamine in rabbits. J Appl Toxicol 1986;6:431-6.
8. Gobba F, Galassi C, Imbriani M, et al. Acquired dyschromatopsia among styrene-exposed workers. J Occup Med 1991;33:761-5.
9. Fallas C, Fallas J, Maslard P, et al. Subclinical impairment of colour vision among workers exposed to styrene. Br J Ind Med 1992;49:679-82.
10. Chia SE, Jeyaratnam J, Ong CN, et al. Impairment of color vision among workers exposed to low concentrations of styrene. Am J Ind Med 1994;26:481-8.
11. Eguchi T, Kishi R, Harabuchi I, et al. Impaired colour discrimination among workers exposed to styrene: Relevance of a urinary metabolite. Occup Environ Med 1995;52:534-8.
12. Mergler D, Huel G, Belanger S, et al. Surveillance of early neurotoxic dysfunction. Neurotoxicology 1996;17:803-12.
13. Gobba F. Color vision: A sensitive indicator of exposure to neurotoxins. Neurotoxicology 2000;21:857-62.
14. ACGIH (American Conference of Governmental Industrial Hygienists). Threshold Limit Values for Chemical Substances and Physical Agents and Biological Exposure Indices. ACGIH, 1997.
15. JSOH (Japan Society for Occupational Health). Recommendation of occupational exposure limits (1999-2000). J Occup Health 1999;41:191-206.
16. Campagna D, Gobba F, Mergler D, et al. Color vision loss among styrene-exposed workers neurotoxicological threshold assessment. Neurotoxicology 1996;17:367-73.
17. Triebig G, Stark T, Ihrig A, et al. Intervention study on acquired color vision deficiencies in styrene-exposed workers. J Occup Environ Med 2001;43:494-500.
18. Castillo L, Baldwin M, Sassine MP, et al. Cumulative exposure to styrene and visual functions. Am J Ind Med 2001;39:351-60.
19. Bardodej Z, Bardodejova E. Biotransformation of ethyl benzene, styrene, and alpha-methylstyrene in man. Am Ind Hyg Assoc J 1970;31:206-9.
20. Pokorny J, Smith VS, Verriest G, et al. Congenital and Acquired Color Vision Defects. New York: Grune and Stratton, 1979.
21. Ikeda M, Koizumi A, Miyasaka M, et al. Styrene exposure and biologic monitoring in FRP boat production plants. Int Arch Occup Environ Health 1982;49:325-39.
22. Bowman KJ. A method for quantitative scoring of the Farnsworth Panel D-15. Acta Ophthalmol 1982;60:907-16.
23. Shirley EA. A nonparametric equivalent of Williams' test for contrasting increasing dose levels of a treatment. Biometrics 1977;33:386-9.
24. Williams DA. A note on Shirley's nonparametric test for comparing several dose levels with a zero-dose level. Biometrics 1986;42:183-6.
25. Bowman MJ, Collins MJ, Henry CJ. The effect of age on performance on the panel D-15 and desaturated D-15: A quantitative evaluation. In: Verriest G, ed. Colour Vision Deficiencies VII. Hague; Boston: W. Junk Publishers, 1984;9:227-31.
26. Kishi R, Eguchi T, Yuasa J, et al. Effects of low-level occupational exposure to styrene on color vision: Dose relation with a urinary metabolite. Environ Res 2001;85:25-30.
27. Gobba F, Cavalleri A. Evolution of color vision loss induced by occupational exposure to chemicals. Neurotoxicology 2000;21:777-81.